ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "2d42ad1b-296f-4ff7-90a9-b016c8403481"}, "_deposit": {"id": "8058", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "8058"}, "status": "published"}, "_oai": {"id": "oai:soar-ir.repo.nii.ac.jp:00008058", "sets": ["883"]}, "author_link": ["22332", "22333", "22334", "22335"], "item_1628147817048": {"attribute_name": "出版タイプ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_ab4af688f83e57aa", "subitem_version_type": "AM"}]}, "item_6_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2010-11", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "12", "bibliographicPageEnd": "2052", "bibliographicPageStart": "2048", "bibliographicVolumeNumber": "32", "bibliographic_titles": [{"bibliographic_title": "CLINICAL THERAPEUTICS"}]}]}, "item_6_description_20": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Background: Enzyme replacement therapy (ERT) with imiglucerase is a well-established, effective treatment for Gaucher disease. However, there have been no published reports regarding the excretion of imiglucerase into human breast milk and its effects on the nursing infant. Objective: This letter reports on the successful pregnancy and lactation of a patient with Gaucher disease receiving treatment with imiglucerase, and the subsequent distribution and excretion of imiglucerase in human breast milk. Methods: A 39-year-old Japanese female (height, 164 cm; weight, 55 kg) with Gaucher disease had 2 successful pregnancies and continued ERT through both. The study was conducted 6 months after the first delivery. She was administered a 1-hour infusion of imiglucerase 60 U/kg that coincided with her regular every-2-week regimen. Serum and breast-milk samples were obtained before and up to 24 hours after administration. Breast-milk samples were also obtained from 10 nursing mothers with galactorrhea as controls. Results: The preinfusion level of breast-milk beta-glucocerebrosidase was 0.008 nmol/h/mL. The peak of serum beta-glucocerebrosidase activity (0.119 nmol/h/mL) was obtained at the end of the 1-hour infusion period. Slightly increased enzymatic activity (0.016 nmol/h/mL) was observed in the first breast milk sampled after imiglucerase infusion. Conclusions: We report a case of successful pregnancy and breastfeeding in a Japanese patient with Gaucher disease. A small amount of imiglucerase was found to be excreted into human breast milk, but only in the first milk produced after infusion. (Clin Ther. 2010;32:2048-2052)", "subitem_description_type": "Abstract"}]}, "item_6_description_30": {"attribute_name": "資源タイプ(コンテンツの種類)", "attribute_value_mlt": [{"subitem_description": "Article", "subitem_description_type": "Other"}]}, "item_6_description_5": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "CLINICAL THERAPEUTICS. 32(12):2048-2052 (2010)", "subitem_description_type": "Other"}]}, "item_6_link_3": {"attribute_name": "信州大学研究者総覧へのリンク", "attribute_value_mlt": [{"subitem_link_text": "Sekijima, Yoshiki", "subitem_link_url": "https://soar-rd.shinshu-u.ac.jp/profile/ja.WhLNuakh.html"}, {"subitem_link_text": "Kosho, Tomoki", "subitem_link_url": "https://soar-rd.shinshu-u.ac.jp/profile/ja.uhfpuakh.html"}, {"subitem_link_text": "Fukushima, Yoshimitsu", "subitem_link_url": "https://soar-rd.shinshu-u.ac.jp/profile/ja.OUnVuUkh.html"}]}, "item_6_link_67": {"attribute_name": "WoS", "attribute_value_mlt": [{"subitem_link_text": "Web of Science", "subitem_link_url": "http://gateway.isiknowledge.com/gateway/Gateway.cgi?\u0026GWVersion=2\u0026SrcAuth=ShinshuUniv\u0026SrcApp=ShinshuUniv\u0026DestLinkType=FullRecord\u0026DestApp=WOS\u0026KeyUT=000285276800007"}]}, "item_6_publisher_4": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "ELSEVIER"}]}, "item_6_relation_47": {"attribute_name": "PubMed", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "21118740"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://pubmed.ncbi.nlm.nih.gov/21118740", "subitem_relation_type_select": "PMID"}}]}, "item_6_relation_48": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "10.1016/j.clinthera.2010.11.008"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1016/j.clinthera.2010.11.008", "subitem_relation_type_select": "DOI"}}]}, "item_6_rights_62": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "Copyright© 2010 Elsevier HS Journals, Inc."}]}, "item_6_select_64": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "author"}]}, "item_6_source_id_35": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0149-2918", "subitem_source_identifier_type": "PISSN"}]}, "item_6_source_id_39": {"attribute_name": "NII ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0149-2918", "subitem_source_identifier_type": "PISSN"}]}, "item_6_source_id_40": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AA00143411", "subitem_source_identifier_type": "NCID"}]}, "item_6_text_69": {"attribute_name": "wosonly authkey", "attribute_value_mlt": [{"subitem_text_value": "Gaucher disease; glucocerebrosidase; enzyme replacement therapy; imiglucerase; lactation; human milk"}]}, "item_6_text_70": {"attribute_name": "wosonly keywords", "attribute_value_mlt": [{"subitem_text_value": "BONE-DISEASE; TYPE-1; GLUCOCEREBROSIDASE"}]}, "item_6_textarea_68": {"attribute_name": "wosonly abstract", "attribute_value_mlt": [{"subitem_textarea_value": "Background: Enzyme replacement therapy (ERT) with imiglucerase is a well-established, effective treatment for Gaucher disease. However, there have been no published reports regarding the excretion of imiglucerase into human breast milk and its effects on the nursing infant. Objective: This letter reports on the successful pregnancy and lactation of a patient with Gaucher disease receiving treatment with imiglucerase, and the subsequent distribution and excretion of imiglucerase in human breast milk. Methods: A 39-year-old Japanese female (height, 164 cm; weight, 55 kg) with Gaucher disease had 2 successful pregnancies and continued ERT through both. The study was conducted 6 months after the first delivery. She was administered a 1-hour infusion of imiglucerase 60 U/kg that coincided with her regular every-2-week regimen. Serum and breast-milk samples were obtained before and up to 24 hours after administration. Breast-milk samples were also obtained from 10 nursing mothers with galactorrhea as controls. Results: The preinfusion level of breast-milk beta-glucocerebrosidase was 0.008 nmol/h/mL. The peak of serum beta-glucocerebrosidase activity (0.119 nmol/h/mL) was obtained at the end of the 1-hour infusion period. Slightly increased enzymatic activity (0.016 nmol/h/mL) was observed in the first breast milk sampled after imiglucerase infusion. Conclusions: We report a case of successful pregnancy and breastfeeding in a Japanese patient with Gaucher disease. A small amount of imiglucerase was found to be excreted into human breast milk, but only in the first milk produced after infusion. (Clin Ther. 2010;32:2048-2052) (C) 2010 Elsevier HS Journals, Inc."}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Sekijima,  Yoshiki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "22332", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ohashi,  Toya", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "22333", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kosho,  Tomoki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "22334", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Fukushima,  Yoshimitsu", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "22335", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2015-09-25"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "Successful_pregnancy_lactation_outcome_patient_Gaucher_disease_receiving_enzyme.pdf", "filesize": [{"value": "172.9 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_note", "mimetype": "application/pdf", "size": 172900.0, "url": {"label": "Successful_pregnancy_lactation_outcome_patient_Gaucher_disease_receiving_enzyme.pdf", "url": "https://soar-ir.repo.nii.ac.jp/record/8058/files/Successful_pregnancy_lactation_outcome_patient_Gaucher_disease_receiving_enzyme.pdf"}, "version_id": "d7574f85-7408-4b12-9329-8fb566acfa96"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Gaucher disease", "subitem_subject_scheme": "Other"}, {"subitem_subject": "glucocerebrosidase", "subitem_subject_scheme": "Other"}, {"subitem_subject": "enzyme replacement therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "imiglucerase", "subitem_subject_scheme": "Other"}, {"subitem_subject": "lactation", "subitem_subject_scheme": "Other"}, {"subitem_subject": "human milk", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Successful Pregnancy and Lactation Outcome in a Patient With Gaucher Disease Receiving Enzyme Replacement Therapy, and the Subsequent Distribution and Excretion of Imiglucerase in Human Breast Milk", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Successful Pregnancy and Lactation Outcome in a Patient With Gaucher Disease Receiving Enzyme Replacement Therapy, and the Subsequent Distribution and Excretion of Imiglucerase in Human Breast Milk", "subitem_title_language": "en"}]}, "item_type_id": "6", "owner": "1", "path": ["883"], "permalink_uri": "http://hdl.handle.net/10091/16905", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2013-04-01"}, "publish_date": "2013-04-01", "publish_status": "0", "recid": "8058", "relation": {}, "relation_version_is_last": true, "title": ["Successful Pregnancy and Lactation Outcome in a Patient With Gaucher Disease Receiving Enzyme Replacement Therapy, and the Subsequent Distribution and Excretion of Imiglucerase in Human Breast Milk"], "weko_shared_id": -1}
  1. 055 医学部附属病院
  2. 0551 学術論文

Successful Pregnancy and Lactation Outcome in a Patient With Gaucher Disease Receiving Enzyme Replacement Therapy, and the Subsequent Distribution and Excretion of Imiglucerase in Human Breast Milk

http://hdl.handle.net/10091/16905
http://hdl.handle.net/10091/16905
7a556c13-f9b1-4e6e-aa44-cc86d936532b
名前 / ファイル ライセンス アクション
Successful_pregnancy_lactation_outcome_patient_Gaucher_disease_receiving_enzyme.pdf Successful_pregnancy_lactation_outcome_patient_Gaucher_disease_receiving_enzyme.pdf (172.9 kB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2013-04-01
タイトル
言語 en
タイトル Successful Pregnancy and Lactation Outcome in a Patient With Gaucher Disease Receiving Enzyme Replacement Therapy, and the Subsequent Distribution and Excretion of Imiglucerase in Human Breast Milk
言語
言語 eng
キーワード
主題Scheme Other
主題 Gaucher disease
キーワード
主題Scheme Other
主題 glucocerebrosidase
キーワード
主題Scheme Other
主題 enzyme replacement therapy
キーワード
主題Scheme Other
主題 imiglucerase
キーワード
主題Scheme Other
主題 lactation
キーワード
主題Scheme Other
主題 human milk
資源タイプ
資源 http://purl.org/coar/resource_type/c_6501
タイプ journal article
著者 Sekijima, Yoshiki

× Sekijima, Yoshiki

WEKO 22332

en Sekijima, Yoshiki

Search repository
Ohashi, Toya

× Ohashi, Toya

WEKO 22333

en Ohashi, Toya

Search repository
Kosho, Tomoki

× Kosho, Tomoki

WEKO 22334

en Kosho, Tomoki

Search repository
Fukushima, Yoshimitsu

× Fukushima, Yoshimitsu

WEKO 22335

en Fukushima, Yoshimitsu

Search repository
信州大学研究者総覧へのリンク
氏名 Sekijima, Yoshiki
URL https://soar-rd.shinshu-u.ac.jp/profile/ja.WhLNuakh.html
信州大学研究者総覧へのリンク
氏名 Kosho, Tomoki
URL https://soar-rd.shinshu-u.ac.jp/profile/ja.uhfpuakh.html
信州大学研究者総覧へのリンク
氏名 Fukushima, Yoshimitsu
URL https://soar-rd.shinshu-u.ac.jp/profile/ja.OUnVuUkh.html
出版者
出版者 ELSEVIER
引用
内容記述タイプ Other
内容記述 CLINICAL THERAPEUTICS. 32(12):2048-2052 (2010)
書誌情報 CLINICAL THERAPEUTICS

巻 32, 号 12, p. 2048-2052, 発行日 2010-11
抄録
内容記述タイプ Abstract
内容記述 Background: Enzyme replacement therapy (ERT) with imiglucerase is a well-established, effective treatment for Gaucher disease. However, there have been no published reports regarding the excretion of imiglucerase into human breast milk and its effects on the nursing infant. Objective: This letter reports on the successful pregnancy and lactation of a patient with Gaucher disease receiving treatment with imiglucerase, and the subsequent distribution and excretion of imiglucerase in human breast milk. Methods: A 39-year-old Japanese female (height, 164 cm; weight, 55 kg) with Gaucher disease had 2 successful pregnancies and continued ERT through both. The study was conducted 6 months after the first delivery. She was administered a 1-hour infusion of imiglucerase 60 U/kg that coincided with her regular every-2-week regimen. Serum and breast-milk samples were obtained before and up to 24 hours after administration. Breast-milk samples were also obtained from 10 nursing mothers with galactorrhea as controls. Results: The preinfusion level of breast-milk beta-glucocerebrosidase was 0.008 nmol/h/mL. The peak of serum beta-glucocerebrosidase activity (0.119 nmol/h/mL) was obtained at the end of the 1-hour infusion period. Slightly increased enzymatic activity (0.016 nmol/h/mL) was observed in the first breast milk sampled after imiglucerase infusion. Conclusions: We report a case of successful pregnancy and breastfeeding in a Japanese patient with Gaucher disease. A small amount of imiglucerase was found to be excreted into human breast milk, but only in the first milk produced after infusion. (Clin Ther. 2010;32:2048-2052)
資源タイプ(コンテンツの種類)
内容記述タイプ Other
内容記述 Article
ISSN
収録物識別子タイプ PISSN
収録物識別子 0149-2918
書誌レコードID
収録物識別子タイプ NCID
収録物識別子 AA00143411
PubMed
識別子タイプ PMID
関連識別子 https://pubmed.ncbi.nlm.nih.gov/21118740
関連名称 21118740
DOI
識別子タイプ DOI
関連識別子 https://doi.org/10.1016/j.clinthera.2010.11.008
関連名称 10.1016/j.clinthera.2010.11.008
権利
権利情報 Copyright© 2010 Elsevier HS Journals, Inc.
出版タイプ
出版タイプ AM
出版タイプResource http://purl.org/coar/version/c_ab4af688f83e57aa
WoS
表示名 Web of Science
URL http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=ShinshuUniv&SrcApp=ShinshuUniv&DestLinkType=FullRecord&DestApp=WOS&KeyUT=000285276800007
戻る
0
views
See details
Views

Versions

Ver.1 2021-03-01 12:44:34.095533
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3